/TECH
Bio-Techne Corporation
TECH • NASDAQTECH • NASDAQ • Healthcare
$51.00-0.91%-0.47
$51.00-0.91%(-0.47)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
61Low Risk
Momentum
22Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
64.8%▼1.6pp
Revenue after COGS
Operating
8.4%▼9.4pp
After operating expenses
Net
6.0%▼8.5pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
110.4
Price vs earnings
EV/EBITDA
38.7
Enterprise value
FCF Yield
3.2%
Cash generation
Earnings Yield
0.9%
Inverse of P/E
Capital Efficiency
3
GoAI Quality ScoreWeak
ROEReturn on Equity
3.8%Fair
ROAReturn on Assets
2.9%Fair
ROICReturn on Invested Capital
3.2%Fair
Financial Health
Current RatioHealthy
3.46
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.30x
Debt repayment capacity (<3x)
Income QualityStrong
3.92
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.22B | $1.16B | $1.14B | $1.11B | $931.03M |
| Gross Profit | $790.27M | $769.73M | $769.82M | $756.50M | $632.85M |
| Gross Margin | 64.8% | 66.4% | 67.7% | 68.4% | 68.0% |
| Operating Income | $102.25M | $206.69M | $298.94M | $296.59M | $237.30M |
| Net Income | $73.40M | $168.10M | $285.26M | $272.05M | $140.41M |
| Net Margin | 6.0% | 14.5% | 25.1% | 24.6% | 15.1% |
| EPS | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 |
Average Price Target
$69.33▲ 35.9% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Bio-Techne Corporation, the average price target is $69.33, with a high forecast of $79.00 and a low forecast of $62.00. The average price target represents a 35.9% increase from the current price of $51.00.
Highest
$79.00
Average
$69.33
Lowest
$62.00
Rating Distribution
Strong Buy
0
0%
Buy
18
72%
Hold
7
28%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Wells Fargo● Maintain
Overweight
2026-02-06UBS● Maintain
Buy
2026-02-05Stifel● Maintain
Hold
2026-02-05Evercore ISI Group● Maintain
In Line
2026-02-05TD Cowen● Maintain
Buy
2026-02-05Citigroup● Maintain
Buy
2026-02-05Evercore ISI Group▼ Downgrade
Outperform→In Line
2026-01-05Argus Research● Maintain
Buy
2025-11-20UBS● Maintain
Buy
2025-11-06Wells Fargo● Maintain
Overweight
2025-11-06Earnings History & Surprises
BEAT RATE
50%
Last 18 quarters
AVG SURPRISE
+1.3%
EPS vs Estimate
BEATS / MISSES
9/7
2 met exactly
LATEST EPS
$0.46
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+6.0%
$0.46 vs $0.43
Q4 '25
-0.3%
$0.42 vs $0.42
Q3 '25
+6.0%
$0.53 vs $0.50
Q2 '25
+9.8%
$0.56 vs $0.51
Q1 '25
+10.5%
$0.42 vs $0.38
Q4 '24
+10.5%
$0.42 vs $0.38
Q3 '24
-1.0%
$0.49 vs $0.49
Q2 '24
+4.3%
$0.48 vs $0.46
Q1 '24
-4.8%
$0.40 vs $0.42
Q4 '23
-6.8%
$0.41 vs $0.44
Q3 '23
$0.55 vs $0.55
Q2 '23
$0.53 vs $0.53
No investor questions available.
Latest News
No news available